Anthony Fauci, director of the National Institute for Allergies and Infectious Diseases at the NIH, speaks about the daily press conference at the White House in Washington on January 21, 2021.
Jonathan Ernst | Reuters
AstraZeneca is likely to release a modified statement on its Covid-19 vaccine after the accuracy of the company’s clinical trial results was questioned earlier this week, White House chief medical officer Dr. Anthony Fauci, on Wednesday.
The company announced the long-awaited results on Monday In his Phase 3 clinical study of the Covid-19 vaccine, which he developed with Oxford University, it was 79% effective in preventing symptomatic illnesses and 100% in treating serious illnesses and hospitalizations.
The next day, the National Institute of Allergies and Infectious Diseases published an unusual statement that said it was informed by the data and safety monitoring body overseeing the study, that the UK-based company may have included information in its US results that provided an “incomplete view of the efficacy data”.
Fauci, director of NIAID, said the DSMB has raised concerns with the US agency because it believes the results in AstraZeneca’s press release are more favorable than more recent data from the vaccine study showed STAT news.
The company is now working with the DSMB and “is likely to make a modified statement,” Fauci told reporters Wednesday during a White House press conference on the pandemic.
Public health and vaccines experts said CNBC AstraZeneca’s data problem is just the latest example in a series of mistakes by the company that could affect people’s willingness to take the vaccine, which may be approved in the US as early as next month.
President Joe Biden’s senior advisor on the pandemic, Andy Slavitt, attempted to reassure Americans about the vaccines on Tuesday, telling CNN: “The public should be confident that nothing will be approved if the FDA gets this data not thoroughly analyzed. “
When the AstraZeneca vaccine is reviewed by the FDA, the agency will “judge what the data says or what it says and whether or not it is approved. Until then, this is all just stuff that will do it.” happen in the background, “said Slavitt.” We believe this transparency and scientific independence are critical to public trust.
AstraZeneca’s vaccine is already approved for use in other countries. The company said in a statement Tuesday that it intends to release results of its primary analysis of the Covid-19 vaccine “within 48 hours”.